Literature DB >> 35063329

Natural history of 10-meter walk/run test performance in spinal muscular atrophy: A longitudinal analysis.

Kristin J Krosschell1, Elise L Townsend2, Michael Kiefer3, Sarah D Simeone4, Katelyn Zumpf5, Leah Welty5, Kathryn J Swoboda4.   

Abstract

As trials and treatments for spinal muscular atrophy (SMA) rapidly evolve, understanding the natural history and potential utility of the 10-meter walk/run test (10MWRT) in ambulant individuals is critical. Study aims were to: 1) establish change over time and across age for 10MWRT time in an untreated natural history cohort of young, ambulatory participants with SMA and 2) identify relations between 10MWRT time and age, SMA type, SMN2 copy number and anthropometrics. Untreated individuals (n = 56) age 2 to 21 years who were enrolled in a long-term natural history study between 2005 and 2014 and met inclusion criteria were included. Linear mixed effects models were used to assess changes in 10MWRT time with age and associations with SMA type, SMN2 copy number, and body mass. SMA type 3b (versus 3a), SMN2 copy number 4 (versus 3) and lower body mass were associated with faster 10MWRT. 10MWRT performance improved between 3 and 8 years of age, was stable between 9 and 10, and gradually declined from 11 to 18. Findings provide the first longitudinal natural history report of 10MWRT time in young individuals with SMA and offer a critical foundation for interpreting childhood change in short distance walking speed with pharmacologic treatment.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  10-meter walk/run test; 10MWRT; Natural history; Outcome measures; Spinal muscular atrophy; Timed function tests

Mesh:

Year:  2021        PMID: 35063329      PMCID: PMC8908436          DOI: 10.1016/j.nmd.2021.08.010

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  44 in total

1.  The 6-minute walk test: normal values for children of 4-11 years of age.

Authors:  A E Lammers; A A Hislop; Y Flynn; S G Haworth
Journal:  Arch Dis Child       Date:  2007-08-03       Impact factor: 3.791

2.  International SMA consortium meeting. (26-28 June 1992, Bonn, Germany).

Authors:  T L Munsat; K E Davies
Journal:  Neuromuscul Disord       Date:  1992       Impact factor: 4.296

3.  Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.

Authors:  E Mazzone; G Vasco; M P Sormani; Y Torrente; A Berardinelli; S Messina; A D'Amico; L Doglio; L Politano; F Cavallaro; S Frosini; L Bello; S Bonfiglio; E Zucchini; R De Sanctis; M Scutifero; F Bianco; F Rossi; M C Motta; A Sacco; M A Donati; T Mongini; A Pini; R Battini; E Pegoraro; M Pane; S Gasperini; S Previtali; S Napolitano; D Martinelli; C Bruno; G Vita; G Comi; E Bertini; E Mercuri
Journal:  Neurology       Date:  2011-07-06       Impact factor: 9.910

4.  Intensity and duration of activity bouts decreases in healthy children between 7 and 13 years of age: a new, higher resolution method to analyze StepWatch Activity Monitor data.

Authors:  Kirsten Tulchin-Francis; Wilshaw Stevens; Kelly A Jeans
Journal:  Physiol Meas       Date:  2014-10-23       Impact factor: 2.833

5.  Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.

Authors:  Richard S Finkel; Eugenio Mercuri; Oscar H Meyer; Anita K Simonds; Mary K Schroth; Robert J Graham; Janbernd Kirschner; Susan T Iannaccone; Thomas O Crawford; Simon Woods; Francesco Muntoni; Brunhilde Wirth; Jacqueline Montes; Marion Main; Elena S Mazzone; Michael Vitale; Brian Snyder; Susana Quijano-Roy; Enrico Bertini; Rebecca Hurst Davis; Ying Qian; Thomas Sejersen
Journal:  Neuromuscul Disord       Date:  2017-11-23       Impact factor: 4.296

6.  Walking speed in children and young adults with neuromuscular disease: comparison between two assessment methods.

Authors:  M Pirpiris; A J Wilkinson; J Rodda; T C Nguyen; R J Baker; G R Nattrass; H K Graham
Journal:  J Pediatr Orthop       Date:  2003 May-Jun       Impact factor: 2.324

7.  Validity and clinical utility of functional assessments in children with cerebral palsy.

Authors:  Nikolaos Chrysagis; Emmanouil K Skordilis; Dimitra Koutsouki
Journal:  Arch Phys Med Rehabil       Date:  2013-11-12       Impact factor: 3.966

8.  Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.

Authors:  Harneet Arora; Rebecca J Willcocks; Donovan J Lott; Ann T Harrington; Claudia R Senesac; Kirsten L Zilke; Michael J Daniels; Dandan Xu; Gihan I Tennekoon; Erika L Finanger; Barry S Russman; Richard S Finkel; William T Triplett; Barry J Byrne; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  Muscle Nerve       Date:  2018-07-24       Impact factor: 3.217

Review 9.  Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy.

Authors:  Didu S T Kariyawasam; Arlene D'Silva; Cindy Lin; Monique M Ryan; Michelle A Farrar
Journal:  Front Neurol       Date:  2019-08-19       Impact factor: 4.003

10.  Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal study.

Authors:  E Mazzone; F Bianco; M Main; M van den Hauwe; M Ash; R de Vries; J Fagoaga Mata; S Stein; R De Sanctis; A D'Amico; C Palermo; L Fanelli; M C Scoto; A Mayhew; M Eagle; M Vigo; A Febrer; R Korinthenberg; M de Visser; K Bushby; F Muntoni; N Goemans; M P Sormani; E Bertini; M Pane; E Mercuri
Journal:  Neuromuscul Disord       Date:  2013-07-01       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.